Caxton Associates (New York)’s Incyte INCY Stock Holding History

Caxton Associates (New York)’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$1.98M	Sell	28,620 -1,076	-4%	-$76.7K	0.06%	103
2024 Q3	$1.96M	Buy	29,696 +1,515	+5%	+$96.6K	0.07%	123
2024 Q2	$1.71M	Hold	28,181	–	–	0.06%	170
2024 Q1	$1.61M	Sell	28,181 -19,636	-41%	-$1.18M	0.09%	157
2023 Q4	$3M	Hold	47,817	–	–	0.15%	81
2023 Q3	$2.76M	Buy	47,817 +10,880	+29%	+$686K	0.38%	44
2023 Q2	$2.3M	Buy	36,937 +29,195	+377%	+$1.95M	0.34%	52
2023 Q1	$560K	Buy	+7,742	New	+$606K	0.08%	237
2022 Q4	–	Sell	-10,265	Closed	-$684K	–	526
2022 Q3	$684K	Buy	+10,265	New	+$758K	0.09%	177
2020 Q3	–	Sell	-2,724	Closed	-$283K	–	411
2020 Q2	$283K	Buy	+2,724	New	+$263K	0.02%	280
2019 Q2	–	Sell	-99,713	Closed	-$8.57M	–	464
2019 Q1	$8.57M	Buy	+99,713	New	+$8.11M	1.25%	25
2017 Q4	–	Sell	-2,200	Closed	-$257K	–	430
2017 Q3	$257K	Buy	+2,200	New	+$278K	0.01%	454

Other funds holding INCY

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Caxton Associates (New York)'s INCY Position: Q4 2024 in Review

Caxton Associates (New York) reduced its Incyte (INCY) stake by 3.6% in Q4 2024, selling an estimated $76.7K and leaving 28,620 shares worth $1.98M. The position accounts for 0.06% of the portfolio, ranked #103.

Caxton Associates (New York) first reported a position in INCY in Q3 2017 and has held it in 12 quarters since. The position peaked at $8.57M in Q1 2019. 651 funds tracked by Wall St. Rank hold INCY as of Q4 2024.

Caxton Associates (New York) held 28,620 shares of Incyte worth $1.98M as of Q4 2024.
Caxton Associates (New York) sold 1,076 Incyte shares in Q4 2024, an estimated $76.7K.
Incyte made up 0.06% of Caxton Associates (New York)'s portfolio in Q4 2024, its #103 holding.
Caxton Associates (New York) first reported a position in Incyte in Q3 2017 and has held it in 12 quarters since.
Caxton Associates (New York)'s Incyte position peaked at $8.57M in Q1 2019.
651 funds tracked by Wall St. Rank held Incyte as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.